Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TK-642 (methadone hydrochloride) Phase 2 Study in Japanese Cancer Patients With Cancer Pain
jRCT2080221268Phase 2
- Sponsor
- Teikoku Seiyaku Co., Ltd.
- Start
- Oct 2010
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of methadone in cancer pain, sponsored by Teikoku Seiyaku Co., Ltd.
02
Drugs
methadone
03
Conditions
cancer pain
Beyond the preview
Go deeper on jRCT2080221268.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080221268.